POS-804 Donor vascular endothelial growth factor gene polymorphism association with acute allograft rejection in live related renal transplant recipient patients

Abstract

Renal allograft rejection risk associated with donor’s vascular endothelial growth factor (VEGF) gene polymorphism remain unelucidated till now. Although, studies have shown, an association of recipient’s VEGF polymorphism with the end-stage renal disease and early acute rejection. VEGF has pleiotropic function, which regulates vasculogenesis, endothelial cell survival signaling. Endothelial cell regulates tonicity, the permeability of blood vessels and egression of allo-stimulated inflammatory cell in intragraft compartments, thus regulate the events of rejection. In the current study, we aimed to investigate the distribution of VEGF -634C>G, -1154 G>A, -1190G>A, -1455T>C, -1499 C>T, -2578 C>A, -2549 18bp Insertion/Deletion, +405 C>G and +936 C>T SNPs among donors and recipients and to evaluate the VEGF mRNA and protein expression in intragraft tissue and in plasma.